the statistics i�m quoting reveal a problem on the level of a tsunami sweeping across the whole of america and europe.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.previous efforts to treat babies with the same protein shortly after birth had failed, schneider said.
.
.